{"id":10048,"date":"2025-07-21T12:57:29","date_gmt":"2025-07-21T12:57:29","guid":{"rendered":"https:\/\/jurmed.ro\/pacienti\/?p=10048"},"modified":"2025-07-21T12:57:29","modified_gmt":"2025-07-21T12:57:29","slug":"hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/","title":{"rendered":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie"},"content":{"rendered":"<p style=\"text-align: justify;\"><u>Lentinanul<\/u>, un polizaharid beta-1,3-glucan cu ramifica\u021bii beta-1,6, extras prin metode standardizate din miceliul Lentinula edodes, reprezint\u0103 unul dintre cele mai studiate <u>imunomodulatoare naturale<\/u>. Produsul <u>Hifas Lentinan<\/u> se distinge prin puritatea extractului \u0219i reproducibilitatea procesului tehnologic, asigur\u00e2nd o activitate farmacologic\u0103 constant\u0103, recunoscut\u0103 \u00een protocoalele medicale integrate.<\/p>\n<p style=\"text-align: justify;\"><u>Mecanisme de Ac\u021biune Imunomodulatoare<\/u><\/p>\n<p style=\"text-align: justify;\">Lentinanul ac\u021bioneaz\u0103 prin stimularea receptoarelor de recunoa\u0219tere (PRR), precum Dectin-1 \u0219i TLR-2\/4, activ\u00e2nd cascade intracelulare ce conduc la:<\/p>\n<p style=\"text-align: justify;\">\u00a0 \u00a0Proliferarea limfocitelor <strong>T helper (Th1)<\/strong> \u0219i a celulelor <strong>Natural Killer (NK)<\/strong>, esen\u021biale \u00een eradicarea celulelor tumorale \u0219i a agen\u021bilor patogeni.<\/p>\n<p style=\"text-align: justify;\">\u00a0 Inducerea produc\u021biei de citokine proinflamatorii (IL-12, IFN-\u03b3) \u0219i reglarea <strong>echilibrului Th1\/Th2<\/strong>, crucial \u00een patologii cu imunitate compromis\u0103.<\/p>\n<p style=\"text-align: justify;\">\u00a0 \u00a0Poten\u021bierea fagocitozei macrofagelor, contribuind la eliminarea detritusului celular post-terapie antitumoral\u0103.<\/p>\n<p style=\"text-align: justify;\"><u>Aplica\u021bii Clinice \u00een Oncologie<\/u><\/p>\n<p style=\"text-align: justify;\">\u00cen Japonia, Lentinanul este aprobat din 1985 ca adjuvant \u00een tratamentul cancerului gastric avansat. Meta-analiza a 15 studii randomizate \u00a0confirm\u0103:<\/p>\n<p style=\"text-align: justify;\">\u00a0 \u00a0Prelungirea supravie\u021buirii globale cu 4\u20136 luni la pacien\u021bii trata\u021bi cu chimioterapie + Lentinan vs. chimioterapie singular.<\/p>\n<p style=\"text-align: justify;\">\u00a0 \u00a0Reducerea toxicit\u0103\u021bii hematologice (neutropenie, trombocitopenie) datorit\u0103 stimul\u0103rii m\u0103duvei osoase.<\/p>\n<p style=\"text-align: justify;\">\u00a0 \u00a0Ameliorarea calit\u0103\u021bii vie\u021bii prin sc\u0103derea asteniei \u0219i a anorexia induse de tratament.<\/p>\n<p style=\"text-align: justify;\">Spre deosebire de imunoterapiile cu anticorpi monoclonali, s-a constatat faptul c\u0103 administrarea de Lentinan nu declan\u0219eaz\u0103 furtuni de citokine sau toxicit\u0103\u021bi hepatice.<\/p>\n<p style=\"text-align: justify;\">Lentinanul regleaz\u0103 <strong>echilibrul citokinelor pro- \u0219i antiinflamatorii<\/strong>, un factor critic \u00een controlul micromediului tumoral. \u00centr-un studiu randomizat efectuat pe pacien\u021bi cu cancer colorectal avansat<strong><sup>\u00a0[2]<\/sup><\/strong>, administrarea Lentinanului (2 mg\/zi, timp de 12 s\u0103pt\u0103m\u00e2ni) <strong>a crescut semnificativ nivelul IL-12 (citokin\u0103 Th1) <\/strong>\u0219i a <strong>redus IL-10 (citokin\u0103 Th2)<\/strong>, reflect\u00e2nd o polarizare spre imunitate celular\u0103 antitumoral\u0103. Aceast\u0103 modulare a contribuit la o supravie\u021buire global\u0103 mai lung\u0103 cu 3,5 luni comparativ cu grupul placebo.<\/p>\n<p style=\"text-align: justify;\"><u>Rolul \u00een Imunonutri\u021bie<\/u><\/p>\n<p style=\"text-align: justify;\">Ca supliment oral, Hifas Lentinan ac\u021bioneaz\u0103 ca prebiotic selectiv, sus\u021bin\u00e2nd microbiota intestinal\u0103 \u0219i integritatea mucoasei digestive. Studiile clinice \u00eel confirm\u0103 ca agent multifunc\u021bional, eficient \u00een combaterea inflama\u021biei intestinale <strong>prin mecanisme antioxidante, imunomodulatoare \u0219i prebiotice<\/strong>.<\/p>\n<p style=\"text-align: justify;\"><strong>Un studiu <\/strong>a explorat capacitatea Lentinanului de<strong> a atenua inflama\u021bia intestinal\u0103<\/strong> \u0219i de a corecta disbioza provocat\u0103 de <strong>administrarea de antibiotice<\/strong> la \u0219oareci. Lentinanul a stimulat <strong>produc\u021bia de butirat \u0219i acetat<\/strong> prin fermentarea selectiv\u0103 de c\u0103tre bacterii benefice, contribuind la: repara\u021bia epiteliului intestinal \u0219i la reglarea metabolismului energetic al enterocitelor .<\/p>\n<p style=\"text-align: justify;\"><u>Concluzii<\/u><\/p>\n<p style=\"text-align: justify;\">Hifas-Lentinan se contureaz\u0103 drept un element esen\u021bial \u00een terapia integrat\u0103, cu eficacitate imunomodulatoare dovedit\u0103, profil de siguran\u021b\u0103 favorabil \u0219i versatilitate terapeutic\u0103 ridicat\u0103. Integrarea sa \u00een protocoalele adjuvante, bazate pe dovezi, reprezint\u0103 o strategie promi\u021b\u0103toare pentru <strong>optimizarea managementului pacien\u021bilor cu patologii neoplazice sau disfunc\u021bii imunitare secundare<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lentinanul, un polizaharid beta-1,3-glucan cu ramifica\u021bii beta-1,6, extras prin metode standardizate din miceliul Lentinula edodes, reprezint\u0103 unul dintre cele mai studiate imunomodulatoare naturale. Produsul Hifas Lentinan se distinge prin puritatea [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":10050,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[67],"tags":[1458,1459],"class_list":["post-10048","post","type-post","status-publish","format-standard","has-post-thumbnail","category-articole","tag-hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie","tag-imunologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti<\/title>\n<meta name=\"description\" content=\"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti\" \/>\n<meta property=\"og:description\" content=\"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Pacienti\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-21T12:57:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"426\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriel\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\"},\"author\":{\"name\":\"Gabriel\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa\"},\"headline\":\"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\",\"datePublished\":\"2025-07-21T12:57:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\"},\"wordCount\":449,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg\",\"keywords\":[\"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\",\"IMUNOLOGIE\"],\"articleSection\":[\"Articole\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\",\"name\":\"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg\",\"datePublished\":\"2025-07-21T12:57:29+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa\"},\"description\":\"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg\",\"width\":300,\"height\":426},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/pacienti\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#website\",\"url\":\"https:\/\/jurmed.ro\/pacienti\/\",\"name\":\"Jurmed - Pacienti\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa\",\"name\":\"Gabriel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/accc2b7d0bf4c444234bb0c0aeb071080c96c00f426597754320e627a9d759fb?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/accc2b7d0bf4c444234bb0c0aeb071080c96c00f426597754320e627a9d759fb?s=96&r=g\",\"caption\":\"Gabriel\"},\"url\":\"https:\/\/jurmed.ro\/pacienti\/author\/gabrielb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti","description":"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/","og_locale":"ro_RO","og_type":"article","og_title":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti","og_description":"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie","og_url":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/","og_site_name":"Jurmed - Pacienti","article_published_time":"2025-07-21T12:57:29+00:00","og_image":[{"width":300,"height":426,"url":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg","type":"image\/jpeg"}],"author":"Gabriel","twitter_misc":{"Scris de":"Gabriel","Timp estimat pentru citire":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/"},"author":{"name":"Gabriel","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa"},"headline":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie","datePublished":"2025-07-21T12:57:29+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/"},"wordCount":449,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg","keywords":["Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie","IMUNOLOGIE"],"articleSection":["Articole"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/","url":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/","name":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie - Jurmed - Pacienti","isPartOf":{"@id":"https:\/\/jurmed.ro\/pacienti\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg","datePublished":"2025-07-21T12:57:29+00:00","author":{"@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa"},"description":"in articolul suport se vorbeste despre hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie","breadcrumb":{"@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#primaryimage","url":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg","contentUrl":"https:\/\/jurmed.ro\/pacienti\/wp-content\/uploads\/sites\/3\/2025\/07\/Hyperfarm-1.jpg","width":300,"height":426},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/pacienti\/hifas-lentinan-un-beta-glucan-cu-aplicatii-adjuvante-in-oncologie-si-imunonutritie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/pacienti\/"},{"@type":"ListItem","position":2,"name":"Hifas-Lentinan: un Beta-Glucan cu aplica\u021bii adjuvante \u00een Oncologie \u0219i Imunonutri\u021bie"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/pacienti\/#website","url":"https:\/\/jurmed.ro\/pacienti\/","name":"Jurmed - Pacienti","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/pacienti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/33a8cfa97687970b1e60b21cfefad2fa","name":"Gabriel","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/pacienti\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/accc2b7d0bf4c444234bb0c0aeb071080c96c00f426597754320e627a9d759fb?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/accc2b7d0bf4c444234bb0c0aeb071080c96c00f426597754320e627a9d759fb?s=96&r=g","caption":"Gabriel"},"url":"https:\/\/jurmed.ro\/pacienti\/author\/gabrielb\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/10048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/comments?post=10048"}],"version-history":[{"count":2,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/10048\/revisions"}],"predecessor-version":[{"id":10052,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/posts\/10048\/revisions\/10052"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/media\/10050"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/media?parent=10048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/categories?post=10048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/pacienti\/wp-json\/wp\/v2\/tags?post=10048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}